Review reveals gut-brain communication disruption drives neuropsychiatric disorders in inflammatory bowel disease, highlighting immune and neuroendocrine pathways as key therapeutic targets.
Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder of the gastrointestinal tract that is frequently associated with neuropsychiatric comorbidities, such as anxiety, depression, and other neurological disorders. Accumulating evidence suggests that these neuropsychiatric disorders are secondary conditions caused by impaired gut-brain communication. The gut-brain axis connects the gut and the brain via neural, endocrine, and immune signaling pathways, disruption of which is usually caused by intestinal microbiota imbalance, intestinal barrier damage, neuroinflammation and immune activation, and neuroendocrine pathway abnormalities. These pathways constitute the pathological basis of the disease spectrum of neuropsychiatric comorbidities in IBD patients. This article comprehensively reviews the core mechanisms and disease spectrum of gut-brain axis-mediated neurological and mental complications in IBD, and discusses potential therapeutic strategies and challenges.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: